William S, Brian F, Stephen H, Severine V, et al. P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension. Am J Gastroenterol 2020;115.
PMID: 33566505